Sharechat Logo

Cannasouth to receive Callaghan funding

Wednesday 3rd July 2019

Text too small?

Medicinal cannabis company Cannasouth will receive funding from Callaghan Innovation to support two of its research programmes.

The government agency will contribute up to $347,008 to the projects during the next three years, conditional on Cannasouth spending up to $566,172 to match the projects' funding. The grant is subject to completion of the formal contract.

Chief Operating Officer Nic Foreman says the research programmes are in the areas of neuropathic pain/drug discovery, and drug delivery systems and optimisation technology. The proposed funding is essential for the company’s technical and commercialisation efforts.

“Securing capital to ensure we make timely progress in research is key to the commercial success of our therapeutic cannabinoids products,” said Foreman.

The announcement comes after the company listed earlier this month after selling $10 million worth of shares at 50 cents each. It was the first share float on the New Zealand Stock Exchange in two years.

The stock first traded at 51 cents but last traded at 29 cents.

The latest funding is additional to three grants Cannasouth and its partners have already received for research already underway or already completed.

Foreman said that, with the funding in place, they will be able to apply to the Ministry of Health for the necessary licences to conduct the research and development projects specified in the grant application.

Plant material from Cannasouth’s Waikato-based cultivation facility will be used in its Waikato Innovation Park laboratory to extract cannabinoid compounds for the proposed projects. The first harvest of plants growing in the facility is expected in the next two months, it said.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Rio Tinto decision following strategic review of Tiwai
Contact says smelter closure is ‘disappointing’
South Port (SPN) Statement on NZAS Tiwai Point Aluminium Smelter Closure
Rio Tinto announcement on Tiwai Aluminium Smelter
Me Today announces equity raising to accelerate growth
Scott Technology Trading Update; Rising to the COVID Challenge
New non-binding indicative offer received from apvg, shareholder meeting deferred
U.S. Added 4.8 Million Jobs in June as Reopened Businesses Rehired
Auditors have a duty to be alert to fraud
Strong sales recovery but uncertainty remains over economic outlook and potential second wave of COVID-19

IRG See IRG research reports